COVID-19 - EUPATI Toolbox

In response to the COVID-19 pandemic, EUPATI has selected content and resources related to medicines research and development, patient education, and other relevant topics.

Related Terms:

- Guidance on the Management of Clinical Trials During the COVID-19 Pandemic (EC, EMA, HMA) - PREVAC (Practical Reviews of Evidence – Volunteers Against Covid-19) - COVID-19: A Global Pandemic—Two Global Perspectives - New ECDC micro-learning course on #COVID19 - Report side effects to National Health Authorities - HTAi Patient & Citizen Involvement Group - E-Bulletin from April 2020

- World Health Organization—Information - World Health Organization—Situation Board - European Medicines Agency - European Center for Disease Prevention and Control - US Centers for Disease Control and Prevention - US Food and Drug Administration

- The Economist - Financial Times - Kaiser Health News - New York Times - BBC Coronavirus

- Frontiers In Medicines - British Medical Journal - Elsevier Coronavirus Information Center - New England Journal of Medicine Coronavirus Center

- EPF (European Patients' Forum) - EURORDIS ((European Organisation for Rare Diseases) - DIA Now In Focus (Drug Information Association) - ISPOR (International Society for Pharmacoeconomics and Outcomes Research) - IPPOSI (Irish Platform for Patients Organisations Science and Industry)

Find Out More

Toolbox

Guidance

Glossary

Creative Commons

Webinars

Back to the top^